Curis
CRIS
#10277
Rank
A$32.83 M
Marketcap
A$0.82
Share price
-1.33%
Change (1 day)
-78.03%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.09. In 2024 the company made an earnings per share (EPS) of A-$9.75 an increase over its 2023 EPS that were of A-$12.53.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-40.66%
2024A-$9.75-22.15%
2023A-$12.53-26.17%
2022A-$16.9722.3%
2021A-$13.87-25.37%
2020A-$18.59-30.93%
2019A-$26.91-2.02%
2018A-$27.47
2016A-$62.43-10%
2015A-$69.37138.1%
2014A-$29.1340%
2013A-$20.81-25%
2012A-$27.7566.67%
2011A-$16.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.89-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.80-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.50-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.01-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.40 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$15.59 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.96-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA